SciELO - Scientific Electronic Library Online

 
vol.29 issue2Prevalence of metabolic changes in children and adolescents: a systematic reviewDiffuse idiopathic musculoskeletal pain in childhood and adolescence author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Paulista de Pediatria

Print version ISSN 0103-0582

Abstract

ZANONI, Lourdes Zélia et al. Usage of L-carnitine as adjuvant in the treatment of dilated cardiomyopathy in a child with Aids. Rev. paul. pediatr. [online]. 2011, vol.29, n.2, pp.289-293. ISSN 0103-0582.  http://dx.doi.org/10.1590/S0103-05822011000200022.

OBJECTIVE: To present the cardiovascular response to L-carnitine of a patient with congestive heart failure caused by dilated cardiomyopathy and human immunodeficiency virus. CASE DESCRIPTION: Child with a clinical history of severe congestive heart failure due to dilated cardiomyopathy caused by acquired immunodeficiency syndrome. The treatment for the symptoms resulted in a poor clinical response. In order to improve the energetic performance/metabolism of cardiomyocytes, therapy with L-carnitine was established. There was significant clinical improvement of the cardiac performance of the patient, even before starting the treatment with antiretroviral drugs. COMMENTS: L-carnitine is a compound that facilitates the transport of long-chain fatty acids into the mitochondria. In this case the administration of L-carnitine appears to be clinically and biochemical justified.

Keywords : L-carnitine; cardiomyopathy, dilated; acquired immunodeficiency syndrome; child.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License